Literature DB >> 24488440

Structural basis for selective cross-reactivity in a bactericidal antibody against inner core lipooligosaccharide from Neisseria meningitidis.

Matthew J Parker1, Kathryn Gomery, Gabrielle Richard, C Roger MacKenzie, Andrew D Cox, James C Richards, Stephen V Evans.   

Abstract

The structure of a antigen-binding fragment (Fab) from the bactericidal monoclonal antibody LPT3-1 specific to lipooligosaccharide (LOS) inner cores from Neisseria meningitidis has been solved in complex with an eight-sugar inner core fragment NmL3 galE lpt3 KOH to 2.69 Å resolution. The epitope is centered about an inner core N-acetylglucosamine residue unique to N. meningitidis and does not include the lipid A moiety, which is disordered in the structure, but is positioned to allow the binding of free and membrane-anchored full-length LOS. All the amino acid residues that contact antigen are of germline origin but, remarkably, two consecutive somatic mutations of serine to glycine in the heavy chain at residues 52 and 52a are positioned to deprive the antibody of advantageous interactions and so weaken binding. However, these mutations are key to allowing selective cross-reactivity with the HepII-3-PEtn inner core variant expressed by 70% of strains. Neisseria meningitidis is a leading cause of disease in the developed world and is especially dangerous to children, who lack the necessary protective antibodies. The structure of Fab LPT3-1 in complex with LOS provides insight into the antibody's selective ability to recognize multiple clinically relevant variations of the LOS inner core from N. meningitidis.

Entities:  

Keywords:  Neisseria meningitidis; X-ray crystallography; antibody; cross-reactivity; lipooligosaccharides

Mesh:

Substances:

Year:  2014        PMID: 24488440     DOI: 10.1093/glycob/cwu009

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  7 in total

1.  Antibacterials: A sweet vaccine.

Authors:  David Bundle
Journal:  Nat Chem       Date:  2016-03       Impact factor: 24.427

2.  Antibody Binding to the O-Specific Antigen of Pseudomonas aeruginosa O6 Inhibits Cell Growth.

Authors:  Gabrielle Richard; C Roger MacKenzie; Kevin A Henry; Evgeny Vinogradov; J Christopher Hall; Greg Hussack
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

3.  Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly-N-acetylglucosamine.

Authors:  Caroline Soliman; Anna K Walduck; Elizabeth Yuriev; Jack S Richards; Colette Cywes-Bentley; Gerald B Pier; Paul A Ramsland
Journal:  J Biol Chem       Date:  2018-02-15       Impact factor: 5.157

4.  An antibacterial vaccination strategy based on a glycoconjugate containing the core lipopolysaccharide tetrasaccharide Hep2Kdo2.

Authors:  Lingbing Kong; Balakumar Vijayakrishnan; Michael Kowarik; Jin Park; Alexandra N Zakharova; Larissa Neiwert; Amirreza Faridmoayer; Benjamin G Davis
Journal:  Nat Chem       Date:  2016-02-01       Impact factor: 24.427

5.  The Combining Sites of Anti-lipid A Antibodies Reveal a Widely Utilized Motif Specific for Negatively Charged Groups.

Authors:  Omid Haji-Ghassemi; Sven Müller-Loennies; Teresa Rodriguez; Lore Brade; Hans-Dieter Grimmecke; Helmut Brade; Stephen V Evans
Journal:  J Biol Chem       Date:  2016-03-01       Impact factor: 5.157

6.  Synthesis of chlamydia lipopolysaccharide haptens through the use of α-specific 3-iodo-Kdo fluoride glycosyl donors.

Authors:  Barbara Pokorny; Paul Kosma
Journal:  Chemistry       Date:  2014-10-29       Impact factor: 5.236

7.  Synthesis of 3-O- and 4-O-(2-aminoethylphosphono) derivatives of methyl l-glycero-α-d-manno-heptopyranoside.

Authors:  Martin Walter; Claudia Kohout; Markus Blaukopf; Paul Kosma
Journal:  Monatsh Chem       Date:  2016-12-08       Impact factor: 1.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.